Mediastinal extraskeletal osteosarcoma

Summary

Mediastinal extraskeletal osteosarcoma (MONDO:0003808) is a disease. A subtype of extraosseous osteosarcoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	mediastinal extraskeletal osteosarcoma
Mondo ID	MONDO:0003808
DOID	DOID:6208
NCIT	C6615
UMLS	C1334675
MedGen	235314
GARD	0023678
Anatomy (UBERON)	UBERON:0003728
Is cancer (heuristic)	no

Also known as: mediastinal extraskeletal osteosarcoma · mediastinal osteogenic sarcoma · mediastinal osteosarcoma · mediastinum osteosarcoma (disease) · osteogenic sarcoma of mediastinum · osteogenic sarcoma of the mediastinum · osteosarcoma of mediastinum · osteosarcoma of the mediastinum

Disease family

This is a subtype of extraosseous osteosarcoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › sarcoma › osteosarcoma › extraosseous osteosarcoma › mediastinal extraskeletal osteosarcoma

Related subtypes (6): kidney osteogenic sarcoma, liver extraskeletal osteosarcoma, childhood extraosseous osteosarcoma, breast extraskeletal osteosarcoma, adult extraskeletal osteosarcoma, central nervous system extraskeletal osteosarcoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.